Work

A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2012-201536

Authors: Laura K Hummers, Carin E Dugowson, Frederick J Dechow, Robert A Wise, Jeffrey Gregory, Joel Michalek, Gayane Yenokyan, John McGready, Fredrick M Wigley

Institutions: Johns Hopkins University, Johns Hopkins Medicine, University of Washington, Acucela (United States), The University of Texas at San Antonio Health Science Center, The University of Texas at San Antonio

Language: English

Topic: Systemic Sclerosis and Related Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Washington, Johns Hopkins University, University of Texas Health Science Center at San Antonio

OpenAlex ID: W2111619936

FWCI: 1.846

Cites: 22

Cited by: 39

Related to: 10